![Paul Fry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Fry
Finanzdirektor/CFO bei
OXFORD INSTRUMENTS PLC
Vermögen: 3 965 $ am 30.06.2026
Profil
Paul Andrew Fry is Chief Financial Officer & Director at Oxford Instruments Plc since 2025.
He is Independent Non-Executive Director at Avacta Group Plc since 2020.
He is Director at Vectura Ltd., Vectura Group Services Ltd., and Vectura Delivery Devices Ltd. since 2019.
He is a Member of The Chartered Institute of Management Accountants.
Former roles include Director-Global Finance Operations at Vodafone Group Plc, Chief Financial Officer & Executive Director at Vectura Group Ltd. from 2019 to 2022, Director at Quadrant Healthcare Ltd., Chief Financial Officer at GlaxoSmithKline SpA, Immunocore Holdings Plc, Immunocore Ltd., and Argenta Syndicate Management Ltd. Education includes an undergraduate degree from the University of Oxford, conferred in 1988.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 98 ( 0 % ) | 3 965 $ | 30.06.2026 |
Aktive Positionen von Paul Fry
| Unternehmen | Position | Beginn |
|---|---|---|
| AVACTA GROUP PLC | Direktor/Vorstandsmitglied | 03.02.2020 |
| OXFORD INSTRUMENTS PLC | Finanzdirektor/CFO | 01.04.2025 |
Vectura Delivery Devices Ltd.
 Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Engages in research, development and commercialisation of pharmaceutical products | Direktor/Vorstandsmitglied | 30.06.2019 |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | 30.06.2019 |
Vectura Ltd.
 Vectura Ltd. Medical SpecialtiesHealth Technology Manufactures medical equipment | Direktor/Vorstandsmitglied | 30.06.2019 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul Fry
| Unternehmen | Position | Ende |
|---|---|---|
| VECTURA GROUP | Vorstandsvorsitzender | 07.11.2019 |
Argenta Syndicate Management Ltd.
 Argenta Syndicate Management Ltd. Multi-Line InsuranceFinance Provides non-life insurance and reinsurance services | Finanzdirektor/CFO | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Finanzdirektor/CFO | - |
| ░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Paul Fry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Vodafone Group Plc
 Vodafone Group Plc Wireless TelecommunicationsCommunications Provides mobile and fixed telecommunications services | Communications |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Consumer Services |
Oxford Instruments Plc
 Oxford Instruments Plc Electronic Equipment/InstrumentsElectronic Technology Operates as a holding company whose subsidiaries provides products and solutions that enable fabrication & characterization of materials and devices | Electronic Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline SpA
 GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products, vaccines and health products | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Quadrant Healthcare Ltd.
 Quadrant Healthcare Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Argenta Syndicate Management Ltd.
Argenta Syndicate Management Ltd. Multi-Line InsuranceFinance Provides non-life insurance and reinsurance services | Finance |
Vectura Ltd.
Vectura Ltd. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Vectura Group Services Ltd.
Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Vectura Delivery Devices Ltd.
Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Engages in research, development and commercialisation of pharmaceutical products | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
Wählen Sie MarketScreener 
